AccelPath has completed the purchase of US-based provider of digital telepathology and laboratory development and management services, DigiPath Solutions, for $2.4m.
DigiPath, which currently provides services to six pathology laboratories in Texas, US, has near-term plans to expand labs in the future.
As part of the acquisition, Rishi Reddy, DigiPath’s founder and chief executive officer, has entered into one-year consulting agreement with AccelPath for integrating its laboratory build and management capabilities.
DigiPath founder and chief executive officer Rishi Reddy said he is impressed with AccelPath’s wealth of knowledge in digital telepathology and, specifically, workflow software technology.
"The Company’s digital telepathology workflow software will facilitate the expansion of DigiPath’s business and take it to the next level of automation," Reddy added.
"Further, we are pleased to bring DigiPath’s laboratory development capabilities to the Company, which will provide a broader product offering to the combined entity and facilitate growth.
"I also look forward to assisting with the development of the Company’s proprietary 3D imaging technology as it relates to digital telemedicine."